Yale Researchers Use Zebrafish to Identify Targeted Autism Drug Candidates | #autism research #drug development #personalized medicine
Yale Researchers Use Zebrafish to Identify Targeted Autism Drug Candidates | #autism research #drug development #personalized medicine
admin
Key findings:
- They created a screening pipeline linking autism genes to testable drug targets (Proceedings of the National Academy of Sciences)
- Focused on KCTD13 gene's role in neuron regulation (tied to head size in zebrafish and autism/schizophrenia in humans)
- Identified existing low-cost drugs that may improve symptoms for certain genetic profiles
This approach could accelerate personalized autism treatments. You can read more in Yale's publications or the journal PNAS.
Eliminar comentario
¿ Seguro que deseas eliminar esté comentario ?